Airsculpt Technologies is trading 5.18% down at $2.56 as broad healthcare weakness drives today’s move, with no fresh company-specific announcement identified for September 9, 2026.
- Recent coverage remains focused on the August 10 revenue miss and reduced adjusted EBITDA outlook, including guidance of $12 million to $14 million.
- The XLV healthcare ETF is down 2.19%, while major U.S. indexes are also lower, indicating sector pressure rather than a new company catalyst is driving today’s move.